Galanin Gene Delivery to the Hippocampus for Mesial Temporal Lobe Epilepsy
PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Edit
Updated: 08/27/2019
Pipeline Type
New Drugs in Development
Phase Of Development
Preclinical
Sponsors and Collaborators
Asklepios BioPharmaceutical, Inc., Epilepsy Foundation (EF)
Mechanism of Action
Gene Therapy
Mechanism Description
Gene deliveryof neuropeptide galanin
Populations Tested In
N/A
Other Resources
Special FDA Designation
Nonprofit or Government Support
Nonprofit
Nonprofit or Government Support Description
Epilepsy Foundation - NTCG 2010
Previous Presentations
Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
N/A
Location of Clinical Trials
N/A
Clinical Trial link